Adult Dosing

Acne vulgaris, acne rosacea, and seborrheic dermatitis

Clenia foaming wash

• Wash affected areas qd-bid

Clenia cream

• Apply a thin layer to affected areas qd-tid

Plexion cleanser

• Wash affected areas qd-bid

Plexion cleansing cloth

• Wash affected areas qd-bid

Plexion SCT

• Apply in a film to entire face qd

Plexion TS

• Apply a thin film to affected areas qd-tid

Rosac wash

• Wash affected areas qd-bid

Rosac cream

• Apply a thin film to affected areas qd-tid

Rosanil cleanser

• Wash affected areas qd-bid

Rosula aquagel

• Apply a thin film to affected areas qd-tid

Rosula cleanser

• Wash affected areas qd-bid

Rosula foam

• Wash affected areas qd-bid

Pediatric Dosing

• Safety and effectiveness in pediatric patients <12 yrs have not been established

Acne vulgaris, acne rosacea, and seborrheic dermatitis

Clenia foaming wash

• Wash affected areas qd-bid

Clenia cream

• Apply a thin layer to affected areas qd-tid

Plexion cleanser

• Wash affected areas qd-bid

Plexion cleansing cloth

• Wash affected areas qd-bid

Plexion SCT

• Apply in a film to entire face qd

Plexion TS

• Apply a thin film to affected areas qd-tid

Rosac wash

• Wash affected areas qd-bid

Rosac cream

• Apply a thin film to affected areas qd-tid

Rosanil cleanser

• Wash affected areas qd-bid

Rosula aquagel

• Apply a thin film to affected areas qd-tid

Rosula cleanser

• Wash affected areas qd-bid

Rosula foam

• Wash affected areas qd-bid

• Indicated in the topical control of acne vulgaris, acne rosacea, and seborrheic dermatitis

• Hypersensitivity to any of the ingredients of the product
• Hypersensitivity to sulfonamides
• Renal disease

• N/A

Renal Dose Adjustment

• Renal impairment: Dose adjustments not defined

Hepatic Dose Adjustment

• Hepatic impairment: Dose adjustments not defined

See Supplemental Patient Information

• Hypersensitivity reactions including Stevens-Johnson syndrome and exfoliative dermatitis may occur with the use of therapy
• Therapy may cause systemic toxic reactions such as agranulocytosis, acute hemolytic anemia, purpura hemorrhagica, drug fever, jaundice and contact dermatitis indicating hypersensivity to sulfonamides
• Exercise caution if areas of denuded or abraded skin are involved
• Indicated for external use only; keep away from eyes
• Therapy may cause reddening and scaling of the epidermis. Uncommon adverse reactions such as dryness, erythema, itching, and edema may occur
• Monitor patients for possible local irritation or sensitization during long-term therapy
• Suspend therapy if excessive irritation develops and institute appropriate therapy

Caution: Use cautiously in

• Hypersensitivity to sulfites

Supplemental Patient Information

• Advise patients to avoid contact with eyes, eyelids, lips, and mucous membranes. If accidental contact occurs, rinse with water. Instruct patients to discontinue use and consult their physician if excessive irritation develops

Pregnancy Category:C

Breastfeeding: Safety unknown. Manufacturer advises caution.

• DERM: Dryness, erythema, itching, edema, erythema multiforme, local irritation
• HYPERSENSITIVITY: Stevens-Johnson syndrome, hypersensitivity reactions

Sulfacetamide

• Antibacterial agent; competitive inhibitor of bacterial para-aminobenzoic acid (PABA), an essential component for bacterial growth
• Metabolism: Unknown
• Excretion: Unknown
• Half-life: Unknown

Sulfur

• Keratolytic agent; also exhibits mild antibacterial and antifungal activity
• Metabolism: Unknown
• Excretion: Unknown
• Half-life: Unknown

US Trade Name(s)

• Clenia
• Plexion
• Plexion TS
• Plexion SCT
• Rosac
• Rosanil
• Rosula

US Availability

Clenia (sulfacetamide/sulfur)

• OTC CRE: 10%/5%
• OTC Foam: 10%/5%

Plexion (sulfacetamide/sulfur)

• OTC Cloth: 10%/5%
• OTC Cleanser: 10%/5%

Plexion TS (sulfacetamide/sulfur)

• OTC SUSP: 10%/5%

Plexion SCT (sulfacetamide/sulfur)

• OTC CRE: 10%/5%

Rosac (sulfacetamide/sulfur)

• OTC Wash: 10%/1%
• OTC CRE: 10%/5%

Rosanil (sulfacetamide/sulfur)

• OTC Cleanser: 10%/5%

Rosula (sulfacetamide/sulfur)

• OTC AQUA GEL: 10%/5%
• OTC Cleanser: 10%/5%
• OTC Foam: 10%/4%

Canadian Trade Name(s)

• Sulfacet-R

Canadian Availability

Sulfacet-R (sulfacetamide/sulfur)

• OTC LOTN: 10%/5%

UK Trade Name(s)

• N/A

UK Availability

• N/A

Australian Trade Name(s)

• N/A

Australian Availability

• N/A

Dermatologic

Dermatologic Topical Agents

Anti-bacterial/Keratolytic Agents; Combination

Pricing data from www.DrugStore.com in U.S.A.

• Clenia 10-5 % CREA [Tube] (UPSHER-SMITH)
  28 % = $139.99
  84 % = $405.99
• Sulfacetamide Sodium-Sulfur 10-5 % LOTN [Tube] (PERRIGO PHARMACEUTICALS)
  60 % = $55.99
  120 % = $95.98
• Rosanil 10-5 % KIT [Box] (GALDERMA)
  1 % = $217.99
  3 % = $625.97
• Sulfacetamide Sodium-Sulfur 10-5 % LOTN [Tube] (PERRIGO PHARMACEUTICALS)
  30 % = $34.99
  90 % = $81.98
• Clenia Foaming Wash 10-5 % EMUL [Bottle] (UPSHER-SMITH)
  340 % = $180
  680 % = $349.95

Warning: This pricing information is subject to change at the sole discretion of DS Pharmacy. For the most current and up-to-date pricing information, please visit drugstore.com.